Back to Search Start Over

Digitalized transcranial electrical stimulation: A consensus statement.

Authors :
Brunoni AR
Ekhtiari H
Antal A
Auvichayapat P
Baeken C
Benseñor IM
Bikson M
Boggio P
Borroni B
Brighina F
Brunelin J
Carvalho S
Caumo W
Ciechanski P
Charvet L
Clark VP
Cohen Kadosh R
Cotelli M
Datta A
Deng ZD
De Raedt R
De Ridder D
Fitzgerald PB
Floel A
Frohlich F
George MS
Ghobadi-Azbari P
Goerigk S
Hamilton RH
Jaberzadeh SJ
Hoy K
Kidgell DJ
Zonoozi AK
Kirton A
Laureys S
Lavidor M
Lee K
Leite J
Lisanby SH
Loo C
Martin DM
Miniussi C
Mondino M
Monte-Silva K
Morales-Quezada L
Nitsche MA
Okano AH
Oliveira CS
Onarheim B
Pacheco-Barrios K
Padberg F
Nakamura-Palacios EM
Palm U
Paulus W
Plewnia C
Priori A
Rajji TK
Razza LB
Rehn EM
Ruffini G
Schellhorn K
Zare-Bidoky M
Simis M
Skorupinski P
Suen P
Thibaut A
Valiengo LCL
Vanderhasselt MA
Vanneste S
Venkatasubramanian G
Violante IR
Wexler A
Woods AJ
Fregni F
Source :
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology [Clin Neurophysiol] 2022 Nov; Vol. 143, pp. 154-165. Date of Electronic Publication: 2022 Sep 05.
Publication Year :
2022

Abstract

Objective: Although relatively costly and non-scalable, non-invasive neuromodulation interventions are treatment alternatives for neuropsychiatric disorders. The recent developments of highly-deployable transcranial electric stimulation (tES) systems, combined with mobile-Health technologies, could be incorporated in digital trials to overcome methodological barriers and increase equity of access. The study aims are to discuss the implementation of tES digital trials by performing a systematic scoping review and strategic process mapping, evaluate methodological aspects of tES digital trial designs, and provide Delphi-based recommendations for implementing digital trials using tES.<br />Methods: We convened 61 highly-productive specialists and contacted 8 tES companies to assess 71 issues related to tES digitalization readiness, and processes, barriers, advantages, and opportunities for implementing tES digital trials. Delphi-based recommendations (>60% agreement) were provided.<br />Results: The main strengths/opportunities of tES were: (i) non-pharmacological nature (92% of agreement), safety of these techniques (80%), affordability (88%), and potential scalability (78%). As for weaknesses/threats, we listed insufficient supervision (76%) and unclear regulatory status (69%). Many issues related to methodological biases did not reach consensus. Device appraisal showed moderate digitalization readiness, with high safety and potential for trial implementation, but low connectivity.<br />Conclusions: Panelists recognized the potential of tES for scalability, generalizability, and leverage of digital trials processes; with no consensus about aspects regarding methodological biases.<br />Significance: We further propose and discuss a conceptual framework for exploiting shared aspects between mobile-Health tES technologies with digital trials methodology to drive future efforts for digitizing tES trials.<br /> (Copyright © 2022 International Federation of Clinical Neurophysiology. All rights reserved.)

Details

Language :
English
ISSN :
1872-8952
Volume :
143
Database :
MEDLINE
Journal :
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Publication Type :
Academic Journal
Accession number :
36115809
Full Text :
https://doi.org/10.1016/j.clinph.2022.08.018